As dysregulated TLR signaling, particularly through TLR7 and TLR9, may contribute to lupus pathogenesis it is possible that the effects of IRF5 in lupus are mediated through alterations in the strength or nature of TLR signaling events. The gene discussed is IRF5; the disease is systemic lupus erythematosus.